Cargando…
Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment
Ulcerative colitis (UC) is a common chronic disease of the large intestine. Current anti-inflammatory drugs prescribed to treat this disease have limited utility due to significant side-effects. Thus, immunotherapies for UC treatment are still sought. In the DSS mouse model of UC, we recently demons...
Autores principales: | Thomas, Sunil, Mercogliano, Giancarlo, Prendergast, George C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629549/ https://www.ncbi.nlm.nih.gov/pubmed/36322599 http://dx.doi.org/10.1371/journal.pone.0276910 |
Ejemplares similares
-
Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitis
por: Thomas, Sunil, et al.
Publicado: (2023) -
384 Alterations in the fungal microbiome in ulcerative colitis
por: Jangi, Sushrut, et al.
Publicado: (2023) -
Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer’s disease
por: Thomas, Sunil, et al.
Publicado: (2023) -
Enteric infections complicating ulcerative colitis
por: Micic, Dejan, et al.
Publicado: (2018) -
Specific immunotherapy ameliorates ulcerative colitis
por: Cai, Min, et al.
Publicado: (2016)